flurbiprofen has been researched along with Glycogen Storage Disease Type I in 1 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
Glycogen Storage Disease Type I: An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheth, UK | 1 |
| Valame, SP | 1 |
| Gupta, KC | 1 |
| Baxi, AJ | 1 |
| Kulkarni, VN | 1 |
| Pispati, PK | 1 |
1 other study available for flurbiprofen and Glycogen Storage Disease Type I
| Article | Year |
|---|---|
Tolerability of ibuprofen and flurbiprofen in G-6-PD deficient subjects: in vitro study.
Topics: Erythrocytes; Female; Flurbiprofen; Glutathione; Glycogen Storage Disease Type I; Humans; Ibuprofen; | 1981 |